Yandamuri S, Filipek B, Obaid A, Lele N, Thurman J, Makhani N, et al. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI Insight. 2023;8: pubmed publisher

Zhou J, Tian Y, Qu Y, Williams M, Yuan Y, Karvas R, et al. The immune checkpoint molecule, VTCN1/B7-H4, guides differentiation and suppresses proinflammatory responses and MHC class I expression in an embryonic stem cell-derived model of human trophoblast. Front Endocrinol (Lausanne). 2023;14:1069395 pubmed publisher

Nisa B, Nakanishi R, Tanaka M, Lin H, Hirabayashi T, Maeshige N, et al. Mild Hyperbaric Oxygen Exposure Enhances Peripheral Circulatory Natural Killer Cells in Healthy Young Women. Life (Basel). 2023;13: pubmed publisher

Lao L, Zeng W, Huang P, Chen H, Jia Z, Wang P, et al. CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance. Cancer Immunol Res. 2023;11:320-338 pubmed publisher

Fatehi Hassanabad A, Schoettler F, Kent W, Adams C, Holloway D, Ali I, et al. Comprehensive characterization of the postoperative pericardial inflammatory response: Potential implications for clinical outcomes. JTCVS Open. 2022;12:118-136 pubmed publisher

Gao X, He J, Sun X, Li F. Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus. iScience. 2022;25:104911 pubmed publisher

Parasar P, Bernard M, Ahn S, Kshirsagar S, Nguyen S, Grzesiak G, et al. Isolation and characterization of uterine leukocytes collected using a uterine swab technique. Am J Reprod Immunol. 2022;88:e13614 pubmed publisher

Chang Y, Syahirah R, Wang X, Jin G, Torregrosa Allen S, Elzey B, et al. Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy. Cell Rep. 2022;40:111128 pubmed publisher

Connors J, Taramangalam B, Cusimano G, Bell M, Matt S, Runner K, et al. Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists. GeroScience. 2022;44:2555-2572 pubmed publisher

Ramos R, Tosch C, Kotsias F, Claudepierre M, Schmitt D, Remy Ziller C, et al. Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. Clin Transl Immunology. 2022;11:e1392 pubmed publisher

Afolabi L, Bi J, Li X, Adeshakin A, Adeshakin F, Wu H, et al. Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat. Front Immunol. 2021;12:701671 pubmed publisher

Reyes M, Filbin M, Bhattacharyya R, Sonny A, Mehta A, Billman K, et al. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci Transl Med. 2021;13: pubmed publisher

Gerace D, Boulanger K, Hyoje Ryu Kenty J, Melton D. Generation of a heterozygous GAPDH-Luciferase human ESC line (HVRDe008-A-1) for in vivo monitoring of stem cells and their differentiated progeny. Stem Cell Res. 2021;53:102371 pubmed publisher

Yu H, Wang X, Li J, Ye Y, Wang D, Fang W, et al. Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma. Mol Ther Oncolytics. 2021;21:158-170 pubmed publisher

O Connor M, Muir R, Chakhtoura M, Fang M, Moysi E, Moir S, et al. A follicular regulatory Innate Lymphoid Cell population impairs interactions between germinal center Tfh and B cells. Commun Biol. 2021;4:563 pubmed publisher

Lugo Reyes S, Pastor N, Gonzalez Serrano E, Yamazaki Nakashimada M, Scheffler Mendoza S, Berrón Ruiz L, et al. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations. J Clin Immunol. 2021;41:1291-1302 pubmed publisher

Ruth J, Gurrea Rubio M, Athukorala K, Rasmussen S, Weber D, Randon P, et al. CD6 is a target for cancer immunotherapy. JCI Insight. 2021;6: pubmed publisher

Bhatt R, Berjis A, Konge J, Mahoney K, Klee A, Freeman S, et al. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Cancer Immunol Res. 2021;9:156-169 pubmed publisher

Man L, Lustgarten Guahmich N, Kallinos E, Redhead Laconte Z, Liu S, Schattman B, et al. Comparison of Human Antral Follicles of Xenograft versus Ovarian Origin Reveals Disparate Molecular Signatures. Cell Rep. 2020;32:108027 pubmed publisher

Liu Y, Tang L, Gao N, Diao Y, Zhong J, Deng Y, et al. Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects. Oncol Lett. 2020;20:2369-2377 pubmed publisher

Li M, Xiong Y, Li M, Zhang W, Liu J, Zhang Y, et al. Depletion but Activation of CD56dimCD16+ NK Cells in Acute Infection with Severe Fever with Thrombocytopenia Syndrome Virus. Virol Sin. 2020;35:588-598 pubmed publisher

Sasawatari S, Okamoto Y, Kumanogoh A, Toyofuku T. Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells. J Immunol. 2020;204:1373-1385 pubmed publisher

Bu S, Li B, Wang Q, Gu T, Dong Q, Miao X, et al. Epithelial ovarian cancer stem‑like cells are resistant to the cellular lysis of cytokine‑induced killer cells via HIF1A‑mediated downregulation of ICAM‑1. Int J Oncol. 2019;55:179-190 pubmed publisher

Mesquitta W, Wandsnider M, Kang H, Thomson J, Moskvin O, Suknuntha K, et al. UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells. Sci Rep. 2019;9:6622 pubmed publisher

Lagou V, Garcia Perez J, Smets I, Van Horebeek L, Vandebergh M, Chen L, et al. Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators. Cell Rep. 2018;25:798-810.e6 pubmed publisher

Judson R, Quarta M, Oudhoff M, Soliman H, Yi L, Chang C, et al. Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential. Cell Stem Cell. 2018;22:177-190.e7 pubmed publisher

Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed publisher